Soluble herpesvirus glycoprotein complex vaccine
US6156319A · kind A · utility
43Cited by
15References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 1997 |
| Grant date | Dec 5, 2000 |
| Priority date | — |
| Expiry date | Jul 31, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a herpes simplex virus vaccine comprising a herpes simplex virus glycoprotein H-glycoprotein L complex. The invention is also directed to a vaccine comprising a DNA encoding a herpes simplex virus glycoprotein H-glycoprotein L complex. Also included is an antibody which specifically binds to a herpes simplex virus glycoprotein H-glycoprotein L complex and DNA encoding the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.